National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

5-[18F]fluorouracil
The fluorine-18 (18F)-radiolabeled pyrimidine analog 5-fluorouracil (5-FU) with positron-emitting activity. Upon administration, 5-[18F]fluorouracil distribution in tumor tissue may be measured with positron emission tomography (PET). The degree of 5-[18F]fluorouracil uptake in tumor tissue may help to predict the response to 5-fluorouracil-based chemotherapy or to determine the response to other therapeutic agents used to treat 5-FU-sensitive tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:3-deazauridine, 4'-iodo-4'-deoxydoxorubicin, 4-hydroxytamoxifen, 4-nitroestrone 3-methyl ether, 5,10-methylenetetrahydrofolate
Next:5-hydroxytryptophan, 50% oxygen/50% nitrous oxide premix, 6-azauridine, 7-cyanoquinocarcinol, 7-hydroxystaurosporine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov